Breaking News Instant updates and real-time market news.

TRIL

Trillium Therapeutics

$6.20

0.05 (0.81%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32

Trillium Therapeutics announces 'at-the-market' issuance program

Trillium Therapeutics announced that it has entered into a sales agreement with Cowen and Company pursuant to which the company may, at its discretion and from time to time during the term of the Sales Agreement, sell, through the Agent, acting as agent and/or principal, such number of common shares of the Company as would result in aggregate gross proceeds to the Company of up to $25M. Sales of Common Shares through the Agent, acting as agent, will be made through "at the market" issuances on the Nasdaq Capital Market at the market price prevailing at the time of each sale, and, as a result, sale prices may vary. No Common Shares will be offered or sold on the Toronto Stock Exchange or any other trading markets in Canada.

TRIL Trillium Therapeutics
$6.20

0.05 (0.81%)

07/17/17
HCWC
07/17/17
INITIATION
Target $7
HCWC
Buy
Trillium Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis started Trillium Therapeutics with a Buy rating and $7 price target. The analyst estimates that Trillium's lead product, TTI-621, which is currently being evaluated in Phase 1 and Phase 1b clinical studies, could be the first marketed CD47-targeting therapy and can generate peak sales of C$1.4B for hematologic and solid tumors.
12/14/17
HCWC
12/14/17
NO CHANGE
Target $10
HCWC
Buy
Trillium price target raised to $10 from $7 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Trillium Therapeutics to $10 saying the company presented "impressive" first results from the Phase 1 study of intratumoral TTI-621 for the treatment of relapsed or refractory mycosis fungoides. The analyst believes TTI-621 could become a "highly efficacious treatment." He reiterates a Buy rating on the shares.
04/13/18
LEER
04/13/18
INITIATION
Target $7
LEER
Market Perform
Trillium Therapeutics resumed with a Market Perform at Leerink
Leerink analyst Jonathan Chan resumed coverage of Trillium Therapeutics with a Market Perform rating and $7 price target. The analyst views the early-stage CD47 space as "competitive with an increasing number of programs in development." he finds it difficult to pick a winner at this time.

TODAY'S FREE FLY STORIES

KHC

Kraft Heinz

$55.92

-0.3 (-0.53%)

12:41
10/23/18
10/23
12:41
10/23/18
12:41
Periodicals
Kraft Heinz to sell Indian asset portfolio to Zydus, Bloomberg reports »

Kraft Heinz has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 01

    Nov

V

Visa

$137.16

-3.48 (-2.47%)

12:40
10/23/18
10/23
12:40
10/23/18
12:40
Options
Visa calls lead puts 2:1 in heavy option volume as earnings approach »

Visa calls lead puts 2:1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 26

    Nov

  • 29

    Jan

LH

LabCorp

$166.46

-2.9 (-1.71%)

12:35
10/23/18
10/23
12:35
10/23/18
12:35
Recommendations
LabCorp analyst commentary  »

LabCorp recent selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ABX

Barrick Gold

$13.36

0.27 (2.06%)

, GOLD

Randgold

$83.26

1.47 (1.80%)

12:35
10/23/18
10/23
12:35
10/23/18
12:35
Hot Stocks
Barrick Gold says Glass Lewis urges holders vote for merger resolutions »

Barrick Gold Corporation…

ABX

Barrick Gold

$13.36

0.27 (2.06%)

GOLD

Randgold

$83.26

1.47 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
10/23/18
10/23
12:35
10/23/18
12:35
General news
Treasury 2-year auction preview: the auction should go ok »

Treasury 2-year auction…

HZNP

Horizon Pharma

$18.06

-1.19 (-6.18%)

, SELB

Selecta Biosciences

$9.72

-3.65 (-27.30%)

12:33
10/23/18
10/23
12:33
10/23/18
12:33
Recommendations
Horizon Pharma, Selecta Biosciences analyst commentary  »

Cowen says Horizon…

HZNP

Horizon Pharma

$18.06

-1.19 (-6.18%)

SELB

Selecta Biosciences

$9.72

-3.65 (-27.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

CIDM

Cinedigm

$0.94

(0.00%)

12:33
10/23/18
10/23
12:33
10/23/18
12:33
Hot Stocks
Cinedigm in partnership with Chinese streaming channel Youku »

Cinedigm announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OC

Owens Corning

$48.25

-0.47 (-0.96%)

12:32
10/23/18
10/23
12:32
10/23/18
12:32
Downgrade
Owens Corning rating change  »

Owens Corning downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FXI

iShares China Large-Cap ETF

$39.47

-1.06 (-2.62%)

12:30
10/23/18
10/23
12:30
10/23/18
12:30
Options
50K iShares Large Cap China Fund Dec 42 - 45 call spreads bought for 48c »

50K iShares Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

, ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

12:25
10/23/18
10/23
12:25
10/23/18
12:25
Conference/Events
JPMorgan pharma and biotech analysts to hold analyst/industry conference call »

Smid Cap Biotech Analyst…

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

AGN

Allergan

$185.90

-1.85 (-0.99%)

SAGE

Sage Therapeutics

$118.28

0.25 (0.21%)

ALKS

Alkermes

$39.00

0.14 (0.36%)

ACAD

Acadia

$21.76

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 19

    Dec

  • 31

    Jan

EDU

New Oriental Education

$52.99

-9.76 (-15.55%)

12:22
10/23/18
10/23
12:22
10/23/18
12:22
Downgrade
New Oriental Education rating change  »

Follow-up: New Oriental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

TSLA

Tesla

$279.50

18.47 (7.08%)

12:21
10/23/18
10/23
12:21
10/23/18
12:21
Periodicals
Mox Reports joins Citron in going long Tesla »

Mox Reports tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IQV

Iqvia

$119.62

-6.74 (-5.33%)

12:20
10/23/18
10/23
12:20
10/23/18
12:20
Options
Vote of confidence in IQVIA Holdings after earnings »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXE

NexGen Energy

$1.89

-0.085 (-4.30%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Conference/Events
NexGen Energy management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/23/18
10/23
12:16
10/23/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEM

Agnico Eagle

$37.18

0.91 (2.51%)

12:15
10/23/18
10/23
12:15
10/23/18
12:15
Options
Agnico Eagle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

EDU

New Oriental Education

$52.96

-9.79 (-15.60%)

12:13
10/23/18
10/23
12:13
10/23/18
12:13
Downgrade
New Oriental Education rating change  »

New Oriental Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

AAPL

Apple

$217.24

-3.38 (-1.53%)

, SPOT

Spotify

$146.50

-2.01 (-1.35%)

12:12
10/23/18
10/23
12:12
10/23/18
12:12
Periodicals
Pandora executive admits to late timing of premium offering, VB says »

According to Venture…

AAPL

Apple

$217.24

-3.38 (-1.53%)

SPOT

Spotify

$146.50

-2.01 (-1.35%)

P

Pandora

$8.47

-0.12 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ANFGY

Antofagasta

$0.00

(0.00%)

12:08
10/23/18
10/23
12:08
10/23/18
12:08
Conference/Events
Antofagasta management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MCD

McDonald's

$175.30

8.77 (5.27%)

, CAT

Caterpillar

$118.17

-10.47 (-8.14%)

12:07
10/23/18
10/23
12:07
10/23/18
12:07
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened sharply…

MCD

McDonald's

$175.30

8.77 (5.27%)

CAT

Caterpillar

$118.17

-10.47 (-8.14%)

MMM

3M

$187.86

-13.55 (-6.73%)

UTX

United Technologies

$127.36

0.94 (0.74%)

VZ

Verizon

$57.08

2.12 (3.86%)

TSLA

Tesla

$276.95

15.92 (6.10%)

CDNS

Cadence Design

$45.20

4.58 (11.28%)

PHM

PulteGroup

$22.27

1.39 (6.66%)

AMAT

Applied Materials

$33.16

-0.36 (-1.07%)

MC

Moelis

$42.49

-8.17 (-16.13%)

CNC

Centene

$130.47

-10.865 (-7.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Dec

  • 14

    Dec

  • 12

    Mar

EBMT

Eagle Bancorp

$16.75

-0.75 (-4.29%)

12:05
10/23/18
10/23
12:05
10/23/18
12:05
Earnings
Eagle Bancorp reports Q3 EPS 30c, two estimate consensus 30c »

"For the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$136.59

-4.05 (-2.88%)

12:05
10/23/18
10/23
12:05
10/23/18
12:05
Conference/Events
Visa management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 26

    Nov

  • 29

    Jan

COG

Cabot Oil & Gas

$22.68

-0.48 (-2.07%)

12:05
10/23/18
10/23
12:05
10/23/18
12:05
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

BA

Boeing

$346.06

-9.92 (-2.79%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Earnings
Fly Intel: What to watch in Boeing's earnings report »

Boeing (BA) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.